Invention Grant
- Patent Title: Pharmaceutical compounds
-
Application No.: US17874564Application Date: 2022-07-27
-
Publication No.: US11999745B2Publication Date: 2024-06-04
- Inventor: Charlotte Fieldhouse , Miles Stuart Congreve
- Applicant: Heptares Therapeutics Limited
- Applicant Address: GB Cambridgeshire
- Assignee: Heptares Therapeutics Limited,Allergan Pharmaceuticals Therapeutics International Limited
- Current Assignee: Heptares Therapeutics Limited,Allergan Pharmaceuticals Therapeutics International Limited
- Current Assignee Address: GB Cambridgeshire; IE Dublin
- Agency: Fish & Richardson P.C.
- Priority: GB 20191 2020.12.18
- Main IPC: C07D487/10
- IPC: C07D487/10 ; A61P25/18 ; C07D271/07
Abstract:
This invention relates to compounds that are agonists of the muscarinic M1 and M4 receptor and which are useful in the treatment of diseases mediated by the muscarinic M1 and/or M4 receptors. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds provided are of formula (1):
and salts thereof.
and salts thereof.
Public/Granted literature
- US20220380379A1 PHARMACEUTICAL COMPOUNDS Public/Granted day:2022-12-01
Information query
